Quiero saber acerca de...

Federal Register / Vol. 86, No. 157 / Wednesday, August 18, 2021 / Notices
jbell on DSKJLSW7X2PROD with NOTICES

within New South Wales District, subject to the following phytosanitary measures:
The citrus must either originate from an area within these approved production areas that is free of the fruit flies Queensland fruit fly, Medfly, and/
or Bactrocera neohumeralis Lesser Queensland fruit fly, or be treated with cold treatment or other approved treatment for the relevant fruit flies.
If the area has Queensland fruit fly or Lesser Queensland fruit fly, cold treatment schedules T107d2 or T107
d3 must be used.
The citrus fruit must be accompanied by a phytosanitary certificate issued by the NPPO of Australia that attests that citrus fruit were produced in a fruit fly pest-free area or that indicates that cold treatment was applied to the consignment during transit to the continental United States, or a combination of PFAs and quarantine treatments; were inspected by the NPPO of Australia and found free of pests of concern. We are not requiring an additional declaration for light brown apple moth because the PRA
considers this pest unlikely to follow the pathway on citrus fruit from these areas.
The citrus fruit is subject to inspection at the port of entry into the United States.
Only commercial consignments of Australian citrus fruit may be imported into the United States.
Fruit must be washed, brushed, surface disinfected in accordance with 7
CFR part 305 and according to treatment schedules listed in the USDA Treatment Manual, treated with fungicide at labeled rates, and waxed at packinghouses.
An operational work plan that details the requirements under which citrus will be safely imported is in place.
The citrus fruit must be imported under permit.
These revised conditions will be listed in the FAVIR database available at https epermits.aphis.usda.gov/
manual. In addition to these specific measures, citrus from Australia will be subject to the general requirements listed in 319.563 that are applicable to the importation of all fruits and vegetables.
Paperwork Reduction Act In accordance with the Paperwork Reduction Act of 1995 44 U.S.C. 3501
et seq., the burden requirements associated with this action are included under the Office of Management and Budget control number 05790049.

VerDate Sep<11>2014

17:34 Aug 17, 2021

Jkt 253001

E-Government Act Compliance The Animal and Plant Health Inspection Service is committed to compliance with the E-Government Act to promote the use of the internet and other information technologies, to provide increased opportunities for citizen access to Government information and services, and for other purposes. For information pertinent to E-Government Act compliance related to this notice, please contact Mr. Joseph Moxey, APHIS Paperwork Reduction Act Coordinator, at 301 8512483.
Congressional Review Act Pursuant to the Congressional Review Act 5 U.S.C. 801 et seq., the Office of Information and Regulatory Affairs designated this action as not a major rule, as defined by 5 U.S.C. 8042.
Authority: 7 U.S.C. 1633, 77017772, and 77817786; 21 U.S.C. 136 and 136a;
7 CFR 2.22, 2.80, and 371.3.
Done in Washington, DC, this 12th day of August 2021.
Mark Davidson, Acting Administrator, Animal and Plant Health Inspection Service.
FR Doc. 202117709 Filed 81721; 8:45 am BILLING CODE 341034P

DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board B292021

Foreign-Trade Zone FTZ 107Des Moines, Iowa; Authorization of Production Activity; Lely North America, Inc. Automated Milking and Feeding Equipment; Pella, Iowa On April 14, 2021, Lely North America, Inc. Lely submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 107E, in Pella, Iowa.
The notification was processed in accordance with the regulations of the FTZ Board 15 CFR part 400, including notice in the Federal Register inviting public comment 86 FR 21686, April 23, 2021. On August 12, 2021, the applicant was notified of the FTZ
Boards decision that no further review of the activity is warranted at this time.
The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Boards regulations, including Section 400.14.
Dated: August 12, 2021.
Andrew McGilvray, Executive Secretary.
FR Doc. 202117691 Filed 81721; 8:45 am BILLING CODE 3510DSP

PO 00000

Frm 00004

Fmt 4703

Sfmt 4703

46177

DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board B582021

Foreign-Trade Zone FTZ 43Battle Creek, Michigan; Notification of Proposed Production Activity; Pfizer, Inc. mRNA COVID19 Vaccine;
Kalamazoo, Michigan Pfizer, Inc. Pfizer submitted a notification of proposed production activity to the FTZ Board for its facilities in Kalamazoo, Michigan. The notification conforming to the requirements of the regulations of the FTZ Board 15 CFR 400.22 was received on August 6, 2021.
Pfizer already has authority to produce pharmaceutical, consumer healthcare and animal healthcare products within Subzone 43E. The current request would add a finished product and a foreign-status material/
component to the scope of authority.
Pursuant to 15 CFR 400.14b, additional FTZ authority would be limited to the specific foreign-status material/component and specific finished product described in the submitted notification as described below and subsequently authorized by the FTZ Board.
Production under FTZ procedures could exempt Pfizer from customs duty payments on the foreign-status material/
component used in export production.
On its domestic sales, for the foreignstatus material/component noted below and in the existing scope of authority, Pfizer would be able to choose the duty rate during customs entry procedures that applies to the mRNA COVID19
vaccine duty-free. Pfizer would be able to avoid duty on foreign-status components which become scrap/waste.
Customs duties also could possibly be deferred or reduced on foreign-status production equipment.
The proposed foreign-status material/
component is mRNA bulk drug substance duty rate6.5%. The company currently intends to ship mRNA bulk drug substance produced at its facility in Andover, Massachusetts Subzone 27R to its Kalamazoo facilities for further processing.
Public comment is invited from interested parties. Submissions shall be addressed to the Boards Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is September 27, 2021.
A copy of the notification will be available for public inspection in the Reading Room section of the Boards website, which is accessible via www.trade.gov/ftz.

E:FRFM18AUN1.SGM

18AUN1